Factors related to successful completion of a 161-km ultramarathon

International Journal of Sports Physiology and Performance

Volumn 6, Issue 1, 2011, Pages 25-37

  Hoffman, Martin D ^a   Fogard, Kevin ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Northern California Health Care System   (United States)

Author keywords

Aerobic exercise; Endurance exercise; Nausea; Nonsteroidal antiinflammatory agents; Running

Indexed keywords

EID: 79952912966     PISSN: 15550265     EISSN: None     Source Type: Journal    
DOI: 10.1123/ijspp.6.1.25     Document Type: Article

References (25)

1. Hoffman MD, Ong JC, Wang G. Historical analysis of participation in 161-km ultramarathons in North America. Int J Hist Sport. 2010:27:1877-1891.
2. Hoffman MD. Performance trends in 161-km ultramarathons. Int J Sports Med. 2010;31:31-37.
3. Hoffman MD, Wegelin JA. The Western States 100-Mile Endurance Run: Participation and performance trends. Med Sci Sports Exerc. 2009;41:2191-2198.
4. Simons SM, Kennedy RG. Gastrointestinal problems in runners. Curr Sports Med Rep. 2004;3:112-116.
5. Rehrer NJ, Brouns F, Beckers EJ, et al. Physiological changes and gastro-intestinal symptoms as a result of ultra-endurance running. Eur J Appl Physiol. 1992;64:1-8.
6. Baska RS, Moses FM, Graeber G, Kearney G. Gastrointestinal bleeding during an ultramarathon. Dig Dis Sci. 1990;35:276-279. (Pubitemid 20072207)
7. Glace B, Murphy C, McHugh M. Food and fluid intake and disturbances in gastrointestinal and mental function during an ultramarathon. Int J Sport Nutr Exerc Metab. 2002;12:414-427.
8. Glace BW, Murphy CA, McHugh MP. Food intake and electrolyte status of ultramarathoners competing in extreme heat. J Am Coll Nutr. 2002;21:553-559. (Pubitemid 36026267)
9. Bishop GW, Fallon KE. Musculoskeletal injuries in a six-day track race: Ultramarathoner's ankle. Clin J Sport Med. 1999;9:216-220.
10. Fallon KE. Musculoskeletal injuries in the ultramarathon: The 1990 Westfield Sydney to Melbourne run. Br J Sports Med. 1996;30:319-323.
11. Hutson MA. Medical implications of ultra marathon running: Observations on a six day track race. Br J Sports Med. 1984;18:44-45.
12. Knechtle B, Duff B, Schulze I, Rosemann T, Senn O. Anthropometry and pre-race experience of finishers and nonfinishers in a multistage ultra-endurance run - Deutschlandlauf 2007. Percept Mot Skills. 2009;109:105-118.
13. Taunton JE, Ryan MB, Clement DB, McKenzie DC, Lloyd-Smith DR, Zumbo BD. A retrospective case-control analysis of 2002 running injuries. Br J Sports Med. 2002;36:95-101.
14. McAnulty S, McAnulty L, Nieman D, Morrow J, Dumke C, Henson D. Effect of NSAID on muscle injury and oxidative stress. Int J Sports Med. 2007;28:909-915. (Pubitemid 350144582)
15. McAnulty SR, Owens JT, McAnulty LS, et al. Ibuprofen use during extreme exercise: Effects on oxidative stress and PGE2. Med Sci Sports Exerc. 2007;39:1075-1079. (Pubitemid 47014135)
16. Nieman DC, Dumke CL, Henson DA, McAnulty SR, Gross SJ, Lind RH. Muscle damage is linked to cytokine changes following a 160 km running race. Brain Behav Immun. 2005;19:398-403. (Pubitemid 41074778)
17. Page AJ, Reid SA, Speedy DB, Mulligan GP, Thompson J. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatroy drug use in an ultraendurance mountain run. Clin J Sport Med. 2007;17:43-48. (Pubitemid 46279923)
18. Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatrory drugs on renal function. Ann Intern Med. 1990;112:559-560.
19. Baker J, Cotter JD, Gerrard DF, Bell DF, Walker RJ. Effects of indomethacin and celecoxib on renal function in athletes. Med Sci Sports Exerc. 2005;37:712-717. (Pubitemid 40628273)
20. Bruso JR, Hoffman MD, Rogers IR, Lee L, Towle G, Hew-Butler T. Rhabdomyolysis and hyponatremia: A cluster of five cases at the 161-km 2009 Western States Endurance Run. Wilderness Environ Med. 2010;21:303-308.
21. Ellis C, Cuthill J, Hew-Butler T, George SM, Rosner MH. Exercise-associated hyponatremia with rhabdomyolysis during endurance exercise. Phys Sportsmed. 2009;37:126-132.
22. Nieman DC, Henson DA, Dumke CL, et al. Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav Immun. 2006;20:578-584. (Pubitemid 44528953)
23. Hoffman MD. Anthropometric characteristics of ultramarathoners. Int J Sports Med. 2008;29:1-4.
24. Hoffman MD, Lebus DK, Ganong AC, Casazza GA, Van Loan M. Body composition of 161-km ultramarathoners. Int J Sports Med. 2010;31:106-109.
25. Wegelin J, Hoffman MD. Variables associated with odds of finishing and finish time in a 161-km ultramarathon. Eur J Appl Physiol. 2011;111:145-153.